Skip to content

Neurocritical care

ISSN 1556-0961

3 papers in the library · 12 citations · publishing 2008-2025

Papers

Sort Most recent Most cited

Impact of Low-Dose Ketamine Infusion on Intracranial Pressure and Hemodynamics in Septic Shock Patients.

Neurocritical care June 18, 2025 Essamedin M Negm, Hossam Tharwat Ali, Hanaa A Nofal et al. 4 citations

Septic shock is a recognized cause of global mortality in intensive care units. Sedation and analgesia management are essential for patients with sepsis or hemodynamic instability. Although considered safe concerning hemodynamic changes, ketamine use might cause a substantial rise in intracranial pressure (ICP). An interventional study was conducted at the intensive care unit of Zagazig...

Ketamine for Critically Ill Patients with Severe Acute Brain Injury: A Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials.

Neurocritical care April 1, 2025 Trine Hjorslev Andreasen, Frederik Andreas Madsen, Marija Barbateskovic et al. 8 citations

Patients with severe acute brain injury have a high risk of a poor clinical outcome due to primary and secondary brain injury. Ketamine reportedly inhibits cortical spreading depolarization, an electrophysiological phenomenon that has been associated with secondary brain injury, making ketamine potentially attractive for patients with severe acute brain injury. The aim of this systematic review...

Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Neurocritical care 2008 Stephane Legriel, Fabrice Bruneel, Odile Spreux-Varoquaux et al.

Posterior reversible encephalopathy syndrome (PRES) is known to occur in association with several substances. However, lysergic acid amide (LSA) is not among the previously reported causes of PRES. We report on a patient with PRES presenting as convulsive status epilepticus associated with hypertensive encephalopathy after LSA ingestion. Magnetic resonance imaging was performed and...